Xerostomia: Clinical Trials

550 trials for Xerostomia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

288 completed, 86 unknown, 69 recruiting, 37 not yet recruiting. 197 Not applicable, 105 Phase 2, 60 Phase 1, 39 Phase 3, 28 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable197Completed 115, Unknown 36, Recruiting 15, Not yet recruiting 13, Active not recruiting 7, Terminated 5, Withdrawn 4, Enrolling by invitation 2
Phase 2105Completed 50, Unknown 16, Recruiting 13, Terminated 13, Not yet recruiting 7, Withdrawn 3, Active not recruiting 2, Enrolling by invitation 1
Phase 160Completed 22, Recruiting 17, Unknown 8, Not yet recruiting 6, Withdrawn 3, Active not recruiting 2, Enrolling by invitation 1, Terminated 1
Phase 339Completed 19, Active not recruiting 7, Unknown 7, Recruiting 3, Terminated 2, Not yet recruiting 1
Phase 428Completed 18, Unknown 5, Recruiting 3, Active not recruiting 1, Withdrawn 1
Early Phase 118Completed 5, Not yet recruiting 4, Recruiting 3, Suspended 2, Terminated 2, Unknown 2

Follow Xerostomia: new trials by email Literature Review of Xerostomia trials Research Report on Xerostomia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Penn SICCA Follow-up Study
Dry Eye, Sjogren's Syndrome
Not yet recruitingUniversity of Pennsylvania2202027-01-012026-03-02
Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers
Deucravacitinib - Systemic Lupus Erythematosus, Sjögren's Disease
Phase 3Not yet recruitingBristol-Myers Squibb23002026-12-312026-09-03
Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye Disease
Infliximab 0.1%, Loteprednol - Sjogren Syndrome, Sjogren Syndrome With Keratoconjunctivitis
Phase 2Not yet recruitingInstituto de Oftalmología Fundación Conde de Valenciana382026-12-012026-06-26
Exosome and Mesenchymal Stem Cell Treatment for Salivary Gland Dysfunction in Primary Sjögren Syndrome
exosomes derived from human umbilical cord mesenchymal stem cells, Mesenchymal Stem Cells (MSC), Placebo - Sjogren Syndrome, Xerostomia
Phase 2Not yet recruitingBanu Erkal302026-12-012026-09-24
Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune Diseases
anti-CD19 CAR-T cells - Systemic Lupus Erthematosus, Systemic Sclerosis (SSc)
Phase 1 / Phase 2Not yet recruitingPeking University Third Hospital92026-11-012026-09-23
R-2487 in Patients With Sjogren's Syndrome (SS)
R-2487 - Sjogren's Syndrome, Sjögren
Phase 1Not yet recruitingRise Therapeutics LLC362026-11-012026-09-28
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
BMS-986553 - Systemic Lupus Erythematosus, Sjögren's Disease
Phase 1Not yet recruitingBristol-Myers Squibb602026-10-302026-10-14
Pain Phenotyping of Rheumatic Diseases - An Observational Study
Bedside quantitative sensory testing - Rheumatic Diseases, Lupus Erythematosus, Systemic
Not yet recruitingNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2252026-10-272026-10-22
Effectiveness of an Oral Exercise Program for Xerostomia in Patients With Sjögren Disease
Oral exercise - Sjogren Syndrome
Not applicableNot yet recruitingNazli Elif Nacar562026-10-262026-10-08
Effects of GLP-1 Receptor Agonists on Saliva and Oral Health
GLP-1 Receptor Agonists - Type 2 Diabetes, Obesity & Overweight
Not yet recruitingKırıkkale University502026-10-162026-09-14
A Study of IBI355 in Participants With Moderate-to-Severe Sjögren's Disease
Part A - Placebo for IBI355, Part B -Telitacicept, PartB -Placebo for Telitacicept - Sjögren's Disease
Phase 2Not yet recruitingInnovent Biologics (Suzhou) Co. Ltd.1982026-10-152026-09-23
Exploratory Study of the Efficacy of HuMoSCs (Human Monocyte-derived Suppressor Cells) on Glandular Involvement in Sjögren's Syndrome
Blood sample, Salivary gland biopsy - Sjogren's Syndrome, Autoimmune Diseases
Not applicableNot yet recruitingCentre Hospitalier Universitaire Dijon202026-10-102026-10-06
Effect of the Dietary Supplement to Alleviate Dry Mouth.
Dietary Supplement - Xerostomia
Not applicableNot yet recruitingLacer S.A.352026-10-012026-09-29
Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic Patients
Meibomian Gland Dysfunction, Dry Eye Syndromes
Not yet recruitingAssiut University1502026-10-012026-09-09
ONO-4915 in Patients With Primary Sjogren's Disease
ONO-4915, Placebo - Sjogren's Disease
Phase 2Not yet recruitingOno Pharmaceutical Co., Ltd.602026-10-012026-09-16
Effects of a 50+ Toothpaste on Halitosis and Oral Comfort in Healthy Adults
50+ Toothpaste, Standard Fluoride Toothpaste - Oral Malodor (Halitosis), Oral Dryness
Not applicableNot yet recruitingUniversity of Pavia302026-10-012026-08-21
A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body
HBM7020 - Rheumatoid Arthritis, Systemic Lupus Erythematosus
Phase 1RecruitingOtsuka Pharmaceutical Development & Commercialization, Inc.632026-09-242026-10-13
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
ATG-201 - Systemic Lupus Erythematosus, Systemic Sclerosis (SSc)
Phase 1Not yet recruitingAntengene Biologics Limited1492026-09-012026-09-21
CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases
RD06-05 CAR-T Cell Injection - SLE - Systemic Lupus Erythematosus, Systemic Sclerosis
Early Phase 1Not yet recruitingNanjing Bioheng Biotech Co., Ltd.302026-09-012026-07-16
New Functional Ingredient for Oral Care
Botanical A, Botanical B, Vehicle (Placebo solution) - Oral Health Related Quality of Life (OHRQoL)
Not applicableNot yet recruitingAccess Business Group1002026-09-012026-08-19

Showing 20 of 550. Sign in to see all of them.

Narrower conditions

Sjogren's Syndrome (318)  ·  Lupus Erythematosus, Systemic (67)  ·  Head and Neck Neoplasms (63)  ·  Dry Eye Syndromes (58)  ·  Arthritis, Rheumatoid (44)  ·  Scleroderma, Systemic (44)  ·  Autoimmune Diseases (39)  ·  Myositis (32)  ·  Scleroderma, Diffuse (20)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (19)  ·  Antiphospholipid Syndrome (15)  ·  Mucositis (15)  ·  Arthritis, Psoriatic (14)  ·  Dermatomyositis (13)

Broader conditions

Stomatognathic Diseases (548)  ·  Mouth Diseases (545)  ·  Salivary Gland Diseases (540)  ·  Eye Diseases (321)  ·  Musculoskeletal Diseases (319)  ·  Skin and Connective Tissue Diseases (319)  ·  Lacrimal Apparatus Diseases (318)  ·  Immune System Diseases (317)  ·  Joint Diseases (316)  ·  Connective Tissue Diseases (313)  ·  Rheumatic Diseases (311)  ·  Arthritis (309)  ·  Autoimmune Diseases (280)  ·  Arthritis, Rheumatoid (274)

Interventions

Pilocarpine (11)  ·  Low-Level Light Therapy (10)  ·  Blood Specimen Collection (9)  ·  Radiotherapy (8)  ·  Acupuncture Therapy (7)  ·  Hydroxychloroquine (7)  ·  ianalumab (7)  ·  Rituximab (6)  ·  Sodium Chloride (5)  ·  Cisplatin (4)  ·  Radiation (4)  ·  Saliva, Artificial (4)  ·  Surveys and Questionnaires (4)  ·  Tacrolimus (4)  ·  Xylitol (4)

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR) (19)  ·  Novartis Pharmaceuticals (14)  ·  Ain Shams University (9)  ·  University of Sao Paulo General Hospital (9)  ·  Peking Union Medical College Hospital (8)  ·  Taipei Veterans General Hospital, Taiwan (8)  ·  Amgen (7)  ·  Assistance Publique - Hôpitaux de Paris (6)  ·  GlaxoSmithKline (6)  ·  Roxane Laboratories (6)  ·  University Hospital, Brest (6)  ·  M.D. Anderson Cancer Center (5)  ·  University of Nove de Julho (5)  ·  University of Pennsylvania (5)  ·  University of Rochester (5)

Countries

United States (173)  ·  France (69)  ·  China (60)  ·  Brazil (36)  ·  Spain (36)  ·  Taiwan (35)  ·  Italy (34)  ·  Turkey (Türkiye) (32)  ·  Germany (31)  ·  Canada (27)  ·  United Kingdom (27)  ·  Poland (23)  ·  Egypt (20)  ·  Australia (18)  ·  Netherlands (18)

Top investigators

Ching-Mao Chang, M.D., Ph.D. (6)  ·  Daniel V Freeland, DO (4)  ·  Aroonwan Lam-ubol, DDS, PhD (3)  ·  Blake M Warner, D.D.S. (3)  ·  Ilias G Alevizos, D.M.D. (3)  ·  Adeline Vanderver, MD (2)  ·  Andreas Charalambous, PhD (2)  ·  Anurag Singh (2)  ·  Charlotte Lynggaard, MD (2)  ·  Darin Brimhall, DO (2)  ·  Emilio C Campos, MD (2)

Results publications

PMID 28279391, PMID 29784145, PMID 20882668, PMID 21280008, PMID 26631691, PMID 30309472, PMID 31095438, PMID 32939030, PMID 37612654, PMID 39839752, PMID 10435146, PMID 10530742, PMID 10775736, PMID 10929962, PMID 11180122, PMID 11208206, PMID 11355268, PMID 11395238, PMID 11491236, PMID 11508435, PMID 12108756, PMID 12673463, PMID 12765470, PMID 14697016, PMID 15361396, PMID 15368347, PMID 15529389, PMID 15590764, PMID 15712851, PMID 15716838, PMID 15990024, PMID 16142864, PMID 16424527, PMID 16648432, PMID 16700739, PMID 16759558, PMID 16980725, PMID 16987829, PMID 16996579, PMID 17000452, PMID 17141973, PMID 17471524, PMID 17665393, PMID 17824884, PMID 17854932, PMID 17986340, PMID 17992096, PMID 18195175, PMID 18808626, PMID 19294365

NIH funding

2018 (5), 2025 (5), 2015 (4), 2023 (4), 2016 (2), 2019 (2), R01CA148707 (2), 2008 (1), 2014 (1), 4UH3DE030431-02 (1), 4UH3DE030856-03 (1), P01CA257907 (1), P30CA006516 (1), P30CA015083 (1), P30CA023074 (1)